WNT-modulating gene silencers as a gene therapy for osteoporosis, bone fracture, and critical-sized bone defects is a research paper published in Molecular Therapy (2022). On theSindex it has a DataRank of 0. It has been cited 71 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: R01AR078230
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: R21AR077557
National Institutes of Health
Grant: P01AI100263
National Institutes of Health
Grant: P01HD080642
National Institutes of Health
Grant: R01AI12135
National Institutes of Health
Grant: R01NS076991
NIAMS NIH HHS
Grant: R01 AR075585
Harvard Medical School
Voyager Therapeutics
Dana-Farber Cancer Institute
International Fibrodysplasia Ossificans Progressiva Association
Pershing Square Sohn Cancer Research Alliance
Burroughs Wellcome Fund
FWCI
9.06
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals